Vaccines List

TAK-003 Dengue Vaccine

TAK-003 is a live attenuated tetravalent dengue vaccine, preventing dengue fever caused by any of the four serotypes of the dengue virus produced by Takeda Pharmaceutical Company LimitedRead more...

TAK-214 Norovirus Vaccine

TAK-214 a vaccine candidate uses virus-like particle (VLP) antigens, which are proteins that precisely mimic the outer surface of norovirus. The vaccine includes antigens from genotypes GI.1 and GII.4, to represent both of the genogroups that cause the majority of human illness.Read more...

TAK-426 Zika Vaccine

TAK-426 (PIZV) is a purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate.Read more...

TetraVax-DV-TV003 Dengue Vaccine

TetraVax-DV-TV003 is a live attenuated recombinant tetravalent dengue vaccine.Read more...

TG4001 HPV Cancer Vaccine

TG4001 is a therapeutic cancer vaccine candidate using an attenuated and modified poxvirus as a vector expressing the HPV16 E6 and E7 proteins and interleukin-2. Read more...

TG4050 Cancer Vaccine

Transgene TG4050 is an individualized therapeutic vaccine designed to stimulate and educate the immune system of patients to recognize and destroy tumor cells. Read more...

TicoVac Vaccine

TicoVac is a vaccine indicated to prevent TBE in individuals 1 year of age and older.Read more...

TIV High Dose Influenza Vaccine

UK marketing authorization was granted for Sanofi Pasteur’s Trivalent Influenza Vaccine High Dose. TIV High Dose is approved for the prevention of influenza in people 65 years of age and older,1 a population that is particularly vulnerable to influenza infection and its complications2Read more...

Trumenba Meningitis B Vaccine

Trumenba is a sterile suspension composed of two recombinant lipidated factor H binding protein (fHBP) variants from N. meningitidis serogroup B, one from fHBP subfamily A and one from subfamily B (A05 and B01, respectively).Read more...

Twinrix Hepatitis Vaccine

Twinrix is a bivalent vaccine that is indicated for active immunization against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus. Read more...

TY014 Anti-Yellow Fever Therapeutic Vaccine

TY014 will be the first therapeutic vaccine specifically targeting the Yellow Fever Virus to enter clinical trials. It is anticipated that a monoclonal antibody therapeutic could be administered to infected cases to reduce disease severity within the patient and their contacts.Read more...

Typbar TCV Typhoid Vaccine

Typbar TCV is the world’s first clinically proven conjugate Typhoid vaccine.Read more...

Typhim VI Typhoid Vaccine

Typhim VI protects against the risk of infection related to Salmonella typh i but it does not confer vis-à-vis protection of Salmonella Paratyphi A or B, or non-typhoid salmonella.Read more...